Human G-MDSCs are neutrophils at distinct maturation stages promoting tumor growth in breast cancer
(2020) In Life Science Alliance 3(11).- Abstract
Myeloid-derived suppressor cells (MDSCs) are known to contribute to immune evasion in cancer. However, the function of the human granulocytic (G)-MDSC subset during tumor progression is largely unknown, and there are no established markers for their identification in human tumor specimens. Using gene expression profiling, mass cytometry, and tumor microarrays, we here demonstrate that human G-MDSCs occur as neutrophils at distinct maturation stages, with a disease-specific profile. G-MDSCs derived from patients with metastatic breast cancer and malignant melanoma display a unique immature neutrophil profile, that is more similar to healthy donor neutrophils than to G-MDSCs from sepsis patients. Finally, we show that primary G-MDSCs from... (More)
Myeloid-derived suppressor cells (MDSCs) are known to contribute to immune evasion in cancer. However, the function of the human granulocytic (G)-MDSC subset during tumor progression is largely unknown, and there are no established markers for their identification in human tumor specimens. Using gene expression profiling, mass cytometry, and tumor microarrays, we here demonstrate that human G-MDSCs occur as neutrophils at distinct maturation stages, with a disease-specific profile. G-MDSCs derived from patients with metastatic breast cancer and malignant melanoma display a unique immature neutrophil profile, that is more similar to healthy donor neutrophils than to G-MDSCs from sepsis patients. Finally, we show that primary G-MDSCs from metastatic breast cancer patients cotransplanted with breast cancer cells, promote tumor growth, and affect vessel formation, leading to myeloid immune cell exclusion. Our findings reveal a role for human G-MDSC in tumor progression and have clinical implications also for targeted immunotherapy.
(Less)
- author
- organization
-
- Cancer Immunology, Malmö (research group)
- Experimental Infection Medicine, Malmö (research group)
- Breast cancer treatment
- The Liquid Biopsy and Tumor Progression in Breast Cancer (research group)
- LUCC: Lund University Cancer Centre
- Translational Neurology (TNY) (research group)
- Neurology, Lund
- Clinical Microbiology, Malmö (research group)
- Clinical infection medicine (research group)
- Division of Medical Microbiology
- WCMM-Wallenberg Centre for Molecular Medicine
- Breast/ovarian cancer
- Melanoma
- Therapeutic pathology
- Division of Translational Cancer Research
- publishing date
- 2020
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Life Science Alliance
- volume
- 3
- issue
- 11
- article number
- e202000893
- publisher
- Rockefeller University Press
- external identifiers
-
- pmid:32958605
- scopus:85091472687
- ISSN
- 2575-1077
- DOI
- 10.26508/LSA.202000893
- language
- English
- LU publication?
- yes
- id
- 6330eeca-6e27-4ac5-9026-ef1631ab17db
- date added to LUP
- 2020-10-22 16:02:32
- date last changed
- 2023-09-24 10:53:16
@article{6330eeca-6e27-4ac5-9026-ef1631ab17db, abstract = {{<p>Myeloid-derived suppressor cells (MDSCs) are known to contribute to immune evasion in cancer. However, the function of the human granulocytic (G)-MDSC subset during tumor progression is largely unknown, and there are no established markers for their identification in human tumor specimens. Using gene expression profiling, mass cytometry, and tumor microarrays, we here demonstrate that human G-MDSCs occur as neutrophils at distinct maturation stages, with a disease-specific profile. G-MDSCs derived from patients with metastatic breast cancer and malignant melanoma display a unique immature neutrophil profile, that is more similar to healthy donor neutrophils than to G-MDSCs from sepsis patients. Finally, we show that primary G-MDSCs from metastatic breast cancer patients cotransplanted with breast cancer cells, promote tumor growth, and affect vessel formation, leading to myeloid immune cell exclusion. Our findings reveal a role for human G-MDSC in tumor progression and have clinical implications also for targeted immunotherapy. </p>}}, author = {{Mehmeti-Ajradini, Meliha and Bergenfelz, Caroline and Larsson, Anna Maria and Carlsson, Robert and Riesbeck, Kristian and Ahl, Jonas and Janols, Helena and Wullt, Marlene and Bredberg, Anders and Kallberg, Eva and Gunnarsdottir, Frida Bjork and Millrud, Camilla Rydberg and Ryden, Lisa and Paul, Gesine and Loman, Niklas and Adolfsson, Jorgen and Carneiro, Ana and Jirstrom, Karin and Killander, Fredrika and Bexell, Daniel and Leandersson, Karin}}, issn = {{2575-1077}}, language = {{eng}}, number = {{11}}, publisher = {{Rockefeller University Press}}, series = {{Life Science Alliance}}, title = {{Human G-MDSCs are neutrophils at distinct maturation stages promoting tumor growth in breast cancer}}, url = {{http://dx.doi.org/10.26508/LSA.202000893}}, doi = {{10.26508/LSA.202000893}}, volume = {{3}}, year = {{2020}}, }